AtriCure Inc
NASDAQ:ATRC
AtriCure Inc
NASDAQ:ATRC
Price:
29.58
USD
-2.83%
Market Closed
Market Cap:
$1.5B
Relative Value
The Relative Value of one
ATRC
stock under the Base Case scenario is
36.38
USD.
Compared to the current market price of 29.58 USD,
AtriCure Inc
is
Undervalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ATRC
Relative Value
Base Case
36.38
USD
Undervaluation 19%
Multiples Across Competitors
ATRC Competitors Multiples
AtriCure Inc Competitors
AtriCure Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
AtriCure Inc
NASDAQ:ATRC
|
1.5B USD | 2.8 | -128.7 | 124.1 | -145.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.3B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.4B USD | 17 | 60 | 45.5 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
133.5B USD | 5.3 | 41.1 | 21 | 25.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.5B USD | 3.2 | 24.6 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 5.3 | 36.4 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.4B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.8B USD | 10.9 | 44.2 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46B USD | 2.1 | 26.2 | 10.3 | 17.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34B USD | 6.3 | 22.9 | 16.1 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
